InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
4,984.87
(
-0.52%
)
US TECH 100
16,646.80
(
-1.71%
)
Dow Jones
37,961.56
(
0.49%
)
Brent Oil
87.07
(
0.75%
)
Bitcoin
64,084.79
(
0.90%
)
Post# of 97237
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

MIKE2OO5

Send PM Follow Ignore
Followers 66
Posts 6179
Boards Moderated 0
Alias Born 07/28/2005

MIKE2OO5

Re: None

Monday, 07/27/2015 12:01:00 PM

Monday, July 27, 2015 12:01:00 PM

Post# of 97237
NYMX nice news......

Nymox Pivotal Phase 3 NX-1207 BPH Extension Trial Successfully Meets Primary Endpoint. Company Plans to File for Regulatory Approvals for Fexapotide Triflutate (NX-1207).
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up